Abstract
Sodium valproate (VPA) has been reported to increase the accumulation of the pathologic isoform of prion protein (PrPsc) in scrapie-infected murine neuroblastoma cells. In this study, the effect of VPA on PrPsc accumulation was investigated in murine N2a neuroblastoma cells chronically infected with scrapie strain 22L (N2a-22L). No accumulation of PrPsc was detected after short-term (3 days) or long-term (21 days) treatment of N2a-22L cells with 4.8, 12, 18 or 24 μM VPA. Higher VPA concentrations (240 and 600 μM) also failed to augment PrPsc expression. In conclusion, in our experimental conditions, no deleterious effect was induced by VPA on prions replication.
References
Bach S, N Talarek, T Andrieu, JM Vierfond, Y Mettey, H Galons, D Dormont, L Meijer, C Cullin and M Blondel (2003) Isolation of drugs active against mammalian prions using a yeast-based screening assay.Nat. Biotechnol. 21, 1075–1081.
Baron GS, K Wehrly, DW Dorward, B Chesebro and B Caughey (2002) Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(sc)) into contiguous membranes.EMBO J. 21, 1031–1040.
Blaheta RA and J Cinatl Jr (2002) Anti-tumor mechanisms of valproate: a novel role for an old drug.Med. Res. Rev. 22, 492–511.
Caughey B (2003) Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains.Br. Med. Bull. 66, 109–120.
Caughey B, GJ Raymond, MA Callahan, C Wong, GS Baron and LW Xiong (2001) Interactions and conversions of prion protein isoforms.Adv. Protein Chem. 57, 139–169.
Hall AC, A Brennan, RG Goold, K Cleverley, FR Lucas, PR Gordon-Weeks and PC Salinas (2002) Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.Mol. Cell. Neurosci. 20, 257–270.
Harwood AJ and G Agam (2003) Search for a common mechanism of mood stabilizers.Biochem. Pharmacol. 66, 179–189.
Korth C, BC May, FE Cohen and SB Prusiner (2001) Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.Proc. Natl. Acad. Sci. USA 98, 9836–9841.
Loscher W (2002) Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.CNS Drugs 16, 669–694.
Perez M, AI Rojo, F Wandosell, J Diaz-Nido and J Avila (2003) Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3.Biochem. J. 372, 129–136.
Shaked GM, R Engelstein, I Avraham, H Rosenmann and R Gabizon (2002) Valproic acid treatment results in increased accumulation of prion proteins.Ann. Neurol. 52, 416–420.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dedicated to Pr. Dominique Dormont, who died in November 2003.
Rights and permissions
About this article
Cite this article
Legendre, C., Casagrande, F., Andrieu, T. et al. Sodium valproate does not augment Prpsc in murine neuroblastoma cells. neurotox res 12, 205–208 (2007). https://doi.org/10.1007/BF03033916
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03033916